A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) (Estriol in MS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by University of California, Los Angeles.
Recruitment status was  Active, not recruiting
Washington University School of Medicine
University of Texas Southwestern Medical Center
Ohio State University
University of Medicine and Dentistry New Jersey
University of Chicago
Western Institute for Biomedical Research, Salt Lake City, UT
Johns Hopkins University
University of Kansas
University of Minnesota - Clinical and Translational Science Institute
Mayo Clinic
University of Colorado, Aurora
University of New Mexico
University of Pennsylvania
Dartmouth Medical School, Lebanon, NH
National Multiple Sclerosis Society
Adeona Pharmaceuticals, Ann Arnor, MI
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
First received: March 22, 2007
Last updated: July 11, 2013
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)